Fluicell AB logo

FLUI - Fluicell AB Share Price

SEK28.8 1.0  3.6%

Last Trade - 8:33am

Micro Cap
Market Cap £27.2m
Enterprise Value £25.5m
Revenue £348k
Position in Universe 1282nd / 1869
Unlock FLUI Revenue
Relative Strength (%)
1m +22.2%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -20.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 1.42 2.64 1.05 1.23 2.49 +15.1%
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 30 September 2020,Fluicell AB revenues increased 85% to SEK3.4M. Net lossdecreased 2% to SEK12.7M. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Lower net loss reflects OtherExternal Expenses decrease of 6% to SEK5.3M (expense),Other Operating Income increase from SEK44K to SEK174K(income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


FLUI Revenue Unlock FLUI Revenue

Net Income

FLUI Net Income Unlock FLUI Revenue

Normalised EPS

FLUI Normalised EPS Unlock FLUI Revenue

PE Ratio Range

FLUI PE Ratio Range Unlock FLUI Revenue

Dividend Yield Range

FLUI Dividend Yield Range Unlock FLUI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
FLUI EPS Forecasts Unlock FLUI Revenue
Profile Summary

Fluicell AB is a Sweden-based company within healthcare industry. It commercializes a product portfolio for processing and studying of individual cells, primarily in the field of drug development. The Company’s products comprise research tools BioPen and Dynaflow Resolve. Tools enable researchers to study, process and measure drug impact on individual cells. Also, the Company develops bioprinting technology Biopixlar Retina in both two-dimensional (2D) and three-dimensional (3D) options. Biopixlar Retina creates complex tissue-like structures with control over positioning of individual cells.

Last Annual December 31st, 2019
Last Interim September 30th, 2020
Public Since April 18, 2018
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 11,459,908
Free Float (0.0%)
Eligible for
FLUI Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for FLUI
Upcoming Events for FLUI
Frequently Asked Questions for Fluicell AB
What is the Fluicell AB share price?

As of 8:33am, shares in Fluicell AB are trading at SEK28.8, giving the company a market capitalisation of £27.2m. This share price information is delayed by 15 minutes.

How has the Fluicell AB share price performed this year?

Shares in Fluicell AB are currently trading at SEK28.8 and the price has moved by 0.122k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Fluicell AB price has moved by 0.121k% over the past year.

What are the analyst and broker recommendations for Fluicell AB?

There are no analysts currently covering Fluicell AB.

When will Fluicell AB next release its financial results?

Fluicell AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Fluicell AB dividend yield?

Fluicell AB does not currently pay a dividend.

Does Fluicell AB pay a dividend?

Fluicell AB does not currently pay a dividend.

When does Fluicell AB next pay dividends?

Fluicell AB does not currently pay a dividend.

How do I buy Fluicell AB shares?

To buy shares in Fluicell AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Fluicell AB?

Shares in Fluicell AB are currently trading at SEK28.8, giving the company a market capitalisation of £27.2m.

Where are Fluicell AB shares listed? Where are Fluicell AB shares listed?

Here are the trading details for Fluicell AB:

Country of listing: Sweden
Exchange: STO
Ticker Symbol: FLUI
What kind of share is Fluicell AB?

Based on an overall assessment of its quality, value and momentum, Fluicell AB is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Fluicell AB share price forecast 2021?

We were not able to load any forecast data for Fluicell AB.

How can I tell whether the Fluicell AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fluicell AB. Over the past six months, the relative strength of its shares against the market has been 0.138k%. At the current price of SEK28.8, shares in Fluicell AB are trading at 0.110k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Fluicell AB PE Ratio?

We were not able to find PE ratio data for Fluicell AB.

Who are the key directors of Fluicell AB?

Fluicell AB's management team is headed by:

Victoire Viannay - CEO
Mats Jonasson - CFO
Gavin Jeffries - CTO
Tatsiana Lobovkina - CSO
Stefan Tilk - CHM
Owe Orwar - DRC
Daniel Chiu - IND
Carl Fhager - IND
Who are the major shareholders of Fluicell AB?

Here are the top five shareholders of Fluicell AB based on the size of their shareholding:

Similar to FLUI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.